VEGFA treatment does not affect MDA-MB-231 cell cycle progression or population growth.19 Overexpression of miR-452 and SNAI2 did not change cell proliferation (Supplementary Figure S6), thus differences in the metastatic tumor burdens of each group are not due to differences in growth rates. This evidence concerns the gene VEGFA and metastatic neoplasm.